5-Bromo-2-methoxyphenol
CAS: 37942-01-1
Ref. 3D-FB72058
| 10g | Descatalogado | ||
| 25g | Descatalogado | ||
| 50g | Descatalogado | ||
| 100g | Descatalogado | ||
| 250g | Descatalogado |
Información del producto
Nombre:
5-Bromo-2-methoxyphenol
Sinónimos:
- 2-Methoxy-5-bromophenol
- 3-Hrdroxy-4-Methoxy Bromobenzene
- 3-Hydroxy-4-Methoxy Bromobenzene
- 3-Hydroxy-4-methoxybromobenzene
- 5-Bromo-2-methoxy-phenol
- 5-Bromoguaiacol
- Phenol, 5-bromo-2-methoxy-
Descripción:
Bosutinib is a tyrosine kinase inhibitor that is used to treat chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Bosutinib inhibits the activity of the Bcr-Abl protein, which is overexpressed in CML cells. The drug has been shown to be effective in primary myelofibrosis, a disease characterized by the production of excess blood cells. Bosutinib also binds stereoselectively to primary amines. This drug inhibits the activity of protein kinase C and protein kinase A, which are enzymes involved in cellular function. Bosutinib has been shown to inhibit growth and induce apoptosis in human K562 cells at low doses, with dose-dependent effects.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
203.03 g/mol
Fórmula:
C7H7BrO2
Pureza:
Min. 95%
InChI:
InChI=1S/C7H7BrO2/c1-10-7-3-2-5(8)4-6(7)9/h2-4,9H,1H3
Clave InChI:
InChIKey=OLSJHVZRUFFIPL-UHFFFAOYSA-N
SMILES:
COc1ccc(Br)cc1O
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
